RxDoctor Payments Data

N'djamina Robinson, MD

Family Medicine · Coal City, ILNPI 1821416587

Payments from drug & device makers

$5,104in general payments, 2019–2025

Across 297 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$425
  • Novo Nordisk$413
  • GSK$410
  • Pfizer$353
  • Amgen$332
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$5,104100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,104 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$73,660
Medicare patients
182
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter133$102,749
AustedoDeutetrabenazine12$99,102
JardianceEmpagliflozin54$76,881
MounjaroTirzepatide30$50,651
RybelsusSemaglutide11$21,694
Breo ElliptaFluticasone/Vilanterol50$21,014
EliquisApixaban14$20,213
OzempicSemaglutide13$19,990
MyrbetriqMirabegron13$9,473
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,146
Incruse ElliptaUmeclidinium Bromide16$5,765
Albuterol Sulfate HfaAlbuterol Sulfate164$4,258
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$3,844
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate19$2,901
Levothyroxine Sodium227$2,342

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$410$129,527199 claims
Teva Pharmaceuticals USA, Inc.Austedo$194$99,10212 claims
Boehringer IngelheimJardiance$30$76,88154 claims
Lilly USA, LLCMounjaro$304$50,65130 claims
Novo NordiskRybelsus, Ozempic$413$41,68424 claims
PfizerEliquis$353$20,21314 claims
Astellas Pharma US IncMyrbetriq$24$9,47313 claims
AstraZenecaBreztri Aerosphere$425$8,14613 claims
AbbVieSynthroid$1,220$1,47711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Coal City

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →